News & Publications for:

Timothy Miller

Experimental drug shows early promise against inherited form of ALS, trial indicates

Posted on July 8, 2020

Phase 1/phase 2 trial shows evidence for safety, biological activity of tofersen; phase 3 trial underway Read More

Posted in: Clocks & Sleep, NeuroRestorative Therapy, News Faculty:

Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities

Posted on June 16, 2020

Jinsy A. Andrews, […] Timothy M. Miller, Sabrina Paganoni, Jeffrey D. Rothstein, Jeremy M. Shefner, Zachary Simmons, Michael D. Weiss, Richard S. Bedlack. Muscle and Nerve 2020 Read More

Posted in: Clocks & Sleep, HPAN, NeuroRestorative Therapy, Publications Faculty:

CNS microRNA profiles: a database for cell type enriched microRNA expression across the mouse central nervous system

Posted on March 31, 2020

Nathan Pomper, Yating Liu, Mariah L. Hoye, Joseph D. Dougherty & Timothy M. Miller. Scientific Reports, Volume 10, Issue 1, 1 December 2020, Article number 4921 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty: ,

Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology

Posted on March 17, 2020

Irit Reichenstein, Chen Eitan, […], Timothy M. Miller and Eran Hornstein. Science Translational Medicine, Volume 11, Issue 523, 18 December 2019, Article number eaav5264 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty:

Miller receives international innovation prize

Posted on January 8, 2020

Recognized for developing experimental treatment for ALS Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, News Faculty: